Sir,

A small number of patients with pauci-immune crescentic glomerulonephritis (CrGN) lack circulating anti-neutrophil cytoplasmic autoantibodies (ANCAs) \[[@ref1]\], and the significance and pathogenesis of this disorder are not fully understood. A recent paper reported that ANCA-negative pauci-immune CrGN might represent an independent disease entity, with distinctive features \[[@ref2]\]. In contrast to the many reports describing a strong relationship between neoplasms and glomerulopathies, i.e. membranous nephropathy \[[@ref3]\], there has been a limited number of reports documenting a possible relationship with rapidly progressive glomerulonephritis (RPGN). Serum ANCA levels also tend to be positive in such cases ([Table 1](#tab1){ref-type="table"}).

###### 

Published cases of RPGN associated with non-renal solid malignancies

  Age (years), gender   Organ      Serum ANCA             Citation
  --------------------- ---------- ---------------------- --------------------------------
  64, M                 Stomach    Not mentioned          Intern Med 2008; 47: 1237
  57, M                 Stomach    pANCA(−)/cANCA(−)^a^   Gastric Cancer 2003; 6:267
  60, F                 Lung       pANCA(+)               Am J Kidney Dis 2000; 36: E24
  64, M                 Stomach    cANCA(+)               Int Urol Nephrol 1994; 26: 579
  62, M                 Lung       cANCA(+)               Clin Nephrol 1993; 40: 22
  56, M                 Prostate   cANCA(+)               Clin Nephrol 1993; 40: 22
  77, M                 Prostate   pANCA(+)               Clin Nephrol 1993; 40: 22
  50, M                 Bladder    cANCA(+)               Clin Nephrol 1993; 40: 22

pANCA, perinuclear anti-neutrophil cytoplasmic autoantibodies; cANCA, cytoplasmic anti-neutrophil cytoplasmic autoantibodies.

^a^The method for detection was not specifically described.

A 59-year-old male was hospitalized because of rapid deterioration in renal function over the course of several weeks ([Figure 1](#fig1){ref-type="fig"}). Renal impairment was not evident 7 months earlier \[serum creatinine (sCr), 78.8 μmol/L\]. Although RPGN was indicated, neither myeloperoxidase (MPO)- nor proteinase 3 (PR3)-ANCA was detected in the serum by enzyme-linked immunosorbent assay. A non-specific assay using a commercial fluorescence detection kit also failed to detect serum ANCA. No other organ involvement was evident.

![Change in serum creatinine over time. sCr, serum creatinine concentration; PSL, prednisolone therapy. Arrow and triangle indicate when the renal biopsy and surgery were performed.](sfq022fig1){#fig1}

Unexpectedly, a 4-cm rectal tumour was found concurrently and pathologically diagnosed as a well-differentiated adenocarcinoma. Serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), cancer antigen 125 (CA125) and alpha-fetoprotein (AFP) were all negative. Because the renal function deteriorated even further (sCr, up to 289.4 μmol/L), low-dose oral steroid therapy, i.e. 20 mg/day (0.28 mg/kg/day) prednisolone, was initiated preoperatively based on the presumptive diagnosis of RPGN.

The principal finding of the biopsy, which was performed at Day 13 of the steroid therapy, was CrGN, with 70--80% of the glomeruli (total = 31 glomeruli) exhibiting fibrocellular or fibrous crescents. No immunoglobulins were detected in the glomeruli by immunofluorescent analysis.

Despite a temporary improvement in renal function after the low-dose prednisolone administration at the time of biopsy, the sCr level started to rise again ([Figure 1](#fig1){ref-type="fig"}). Steroid therapy was tapered off to reduce surgery-associated risks, followed by successful resection of the rectal cancer (pT3M0N1). The sCr level declined immediately after the surgery without further medication.

The relapse of progressive renal insufficiency prior to steroid discontinuation and its significant reversal immediately after the surgery suggest that tumour resection rather than the short-term low-dose oral steroid therapy was responsible for the improvement of renal function. Hence, the present case suggests the possibility of ANCA-negative pauci-immune CrGN as a paraneoplastic syndrome.
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